173 related articles for article (PubMed ID: 3091267)
1. Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation.
Aiello FB; Maggiano N; Larocca LM; Piantelli M; Musiani P
Cell Immunol; 1986 Jan; 97(1):131-9. PubMed ID: 3091267
[TBL] [Abstract][Full Text] [Related]
2. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
Schwab R; Crow MK; Russo C; Weksler ME
J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferation.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1988 Aug; 115(1):36-56. PubMed ID: 2969776
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
Vercammen C; Ceuppens JL
Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
[TBL] [Abstract][Full Text] [Related]
6. Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate.
Hara T; Fu SM
J Exp Med; 1985 Apr; 161(4):641-56. PubMed ID: 3920341
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2.
Bloemena E; Van Oers MH; Weinreich S; Schellekens PT
Clin Exp Immunol; 1988 Feb; 71(2):308-13. PubMed ID: 2832109
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes.
Harris DT; Kozumbo WJ; Cerutti PA; Cerottini JC
Cell Immunol; 1987 Oct; 109(1):104-14. PubMed ID: 3115596
[TBL] [Abstract][Full Text] [Related]
9. T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages.
Fiedler W; Sykora KW; Welte K; Kolitz JE; Cunningham-Rundles C; Holloway K; Miller GA; Souza L; Mertelsmann R
Clin Immunol Immunopathol; 1987 Aug; 44(2):206-18. PubMed ID: 3111766
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
Ceuppens JL; Baroja ML
J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
[TBL] [Abstract][Full Text] [Related]
11. Evidence for IL-2 independent proliferation in human T cells.
Laing TJ; Weiss A
J Immunol; 1988 Feb; 140(4):1056-62. PubMed ID: 2830333
[TBL] [Abstract][Full Text] [Related]
12. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
Geppert TD; Lipsky PE
J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
14. The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro.
Bloemena E; Van Oers RH; Weinreich S; Stilma-Meinesz AP; Schellekens PT; Van Lier RA
Eur J Immunol; 1989 May; 19(5):943-6. PubMed ID: 2567675
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
Caspi RR; McAllister CG; Gery I; Nussenblatt RB
Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988
[TBL] [Abstract][Full Text] [Related]
16. Dissection of the role of macrophages in triggering T lymphocytes for interleukin 2 production by monoclonal antibody OKT3.
Fujimoto K; Yamamoto Y; Ohmura T; Kawakami K; Onoue K
Microbiol Immunol; 1986; 30(6):561-72. PubMed ID: 3091996
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory activity of cyclosporine is dependent on the activating signal(s) provided to T cells.
Suthanthiran M
J Pediatr; 1987 Dec; 111(6 Pt 2):1008-11. PubMed ID: 2960793
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
Lillehoj HS; Malek TR; Shevach EM
J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
Bentin J; Carson DA; Vaughan JH; Tsoukas CD
Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
[No Abstract] [Full Text] [Related]
20. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.
Van Wauwe JP; Goossens JG; Beverley PC
J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]